Skip to main content

Table 1 Patient and procedure characteristics of two groups

From: Male urogenital function after robot-assisted and laparoscopic total mesorectal excision for rectal cancer: a prospective cohort study

Variables

R-TME (n = 38)

L-TME (n = 39)

P value

Age (years)

47.75 ± 9.62

46.01 ± 9.37

0.424

BMI (kg/m2)

21.34 ± 2.67

22.03 ± 2.51

0.246

ASA score n(%)

  

0.301

 I

22(57.9%)

27(69.2%)

 

 II

16(42.1%)

12(30.8%)

 

Tumor location (cm)

6.33 ± 2.21

5.82 ± 2.43

0.339

Neoadjuvant therapy n (%)

9(23.7%)

11(28.2%)

0.651

Operation method n (%)

  

0.591

 LAR

32(84.2%)

31(79.5%)

 

 APR

6(15.8%)

8(20.5%)

 

 Stoma n (%)

8(21.1%)

7(17.9%)

0.731

Tumor differentiation n (%)

  

0.826

 Well

5(13.2%)

6(15.4%)

 

 Moderate

25(65.8%)

23(59.0%)

 

 Poor

8(21.0%)

10(25.6%)

 

Tumor stage n (%)

  

0.367

 T1

3(5.3%)

3(7.7%)

 

 T2

10(26.3%)

7(17.9%)

 

 T3

22(57.9%)

24(61.5%)

 

 T4

3(7.9%)

5(12.8%)

 

Nodal stage n (%)

  

0.761

 N0

28(73.7%)

30(76.9%)

 

 N1

7(18.4%)

6(15.4%)

 

 N2

3(7.9%)

3(7.7%)

 

 Adjuvant therapy n (%)

13(34.2%)

15(38.5%)

0.114

  1. BMI body mass index, ASA American Society of Anesthesiologists, LAR low anterior resection, APR abdominoperineal resection